Wegovy received UK marketing authorisation in 2023, and NICE guidance (TA875) supports its use within the NHS for adults with a BMI of at least 35 kg/m (or 30 kg/m with weight-related comorbidities), when provided through specialist weight management services, and for a maximum duration of 2 years
Supporters cited a larger international literature than for several other peptides, while FDA staff said the material it could evaluate remained insufficient for the proposed uses
La Agencia Europea del Medicamento (EMA) y la Red de Jefes de Agencias de Medicamentos (HMA) lanzaron una advertencia sobre el incremento de la venta de medicamentos ilegales adelgazantes en la Unin Europea
Quick Answer: Semaglutide-related diarrhea typically lasts from a few days to several weeks, with most patients experiencing improvement as their body adjusts to the medication and dose stabilizes
Discuss choice with your provider based on goals and tolerability
Increased mitochondrial turnover in the skeletal muscle of fasted, castrated mice is related to the magnitude of autophagy activation and muscle atrophy